USE OF DAPSONE AS A NEUROPROTECTOR IN CEREBRAL INFARCTION

摘要

The invention relates to the use of dapsone as the first effective treatment against the disabling consequences associated with cerebral infarction in patients. Dapsone was evaluated as a neuroprotector in the cerebral infarction model produced by the occlusion of the middle cerebral artery in rats and in patients suffering from acute cerebral infarction caused by thromboembolism. In both studies, dapsone displayed a reduction of between 70 and 90 % in the adverse effects which occur as a consequence of the infarction.